A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database

Clinical and Experimental Rheumatology

Volumn 20, Issue 6, 2002, Pages 767-771

  Geier, David A ^a   Geier, Mark R ^b  

^a MedCon Inc   (United States)

^b Genetic Centers of America   (United States)

Author keywords

Adult; Autoimmune; Hepatitis B; Rheumatoid arthritis; Rubella; Vaccine; VAERS

Indexed keywords

DIPHTHERIA TETANUS VACCINE; HEPATITIS B VACCINE; RUBELLA VACCINE; TETANUS TOXOID;

ADULT; ARTICLE; AUTOIMMUNITY; CHRONIC ARTHRITIS; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RUBELLA; STATISTICAL SIGNIFICANCE; VACCINATION REACTION; FACTUAL DATABASE; MIDDLE AGED; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; STATISTICS; UNITED STATES; VACCINATION;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; FEMALE; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RUBELLA VACCINE; UNITED STATES; VACCINATION;

EID: 0036900993     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. GEIER DA, GEIER MR: Rubella vaccine and arthritic adverse reactions: An analysis of the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1998. Clin Exp Rheumatol 2001; 19: 724-6.
2. GEIER DA, GEIER MR: Hepatitis B vaccination and arthritic adverse reactions: A follow-up analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol 2002; 20: 119.
3. SHOENFELD Y, AARON-MAOR A: Vaccination and autoimmunity-'vaccinosis': A dangerous liaison? J Autoimmunity 2000; 14: 1-10.
4. GEIER DA, GEIER MR: The VAERS and CDC Reportable Disease databases are new tools for those in vaccine related forensic medicine. A case in point: Adult hepatitis B vaccine. The Forensic Examiner 2002; 11: 21-8.
5. GEIER MR, GEIER DA: Vaccine causation of selected adverse reactions: Epidemiology of the Vaccine Adverse Event Reporting System (VAERS). Thimerosal and Vaccines 2002; 1: 32-42.
6. INSTITUTE OF MEDICINE (U.S.): Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC, National Academy Press, 1991, 187-205.
7. TINGLE AJ, POT CH, CHANTLER JK: Prolonged arthritis, viraemia, hypogammaglobulinaemia, and failed seroconversion following rubella immunization. Lancet 1984; 1: 1475-6.
8. TINGLE AJ, ALLEN M, PETTY RE, KETTYLS GD, CHANTLER JK: Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunization. Ann Rheumatic Dis 1986; 45: 110-14.
9. TINGLE AJ, MITCHELL LA, GRACE M, et al.: Randomized double-blind placebo-controlled study on adverse effects of rubella immunization in seronegative women. Lancet 1997; 349: 1277-81.
10. TINGLE AJ, CHANTLER JK, POT KH, PATY DW, FORD DK: Postpartum rubella immunization: Association with development of prolonged arthritis, neurological sequella, and chronic rubella viremia. J Infect Dis 1985; 152: 606-12.
11. ANDRE FE: Clinical experience with a recombinant DNA hepatitis B vaccine. Southeast Asian J Trop Med Public Health 1988; 19: 501-10.
12. POPE JE, STEVENS A, HOWSON W, BELL DA: The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 1998; 25: 1687-93.
13. HONORATI MC, DOLZANI P, MARIANI E, et al.: Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 1997; 112: 2017-27.
14. HONORATI MC, FACCHINI A: Rhematoid epitopes and CD4+ immunodominant regions of recombinant hepatitis B surface antigen. J Rheumatol 1999; 26: 1636.
15. SINGLETON JA, LLOYD JC, MOOTREY GT, SALIVE ME, CHEN RT: An overview of the Vaccine Adverse Events Reporting System (VAERS) as a surveillance system. Vaccine 1999; 17: 2908-17.